Area of research
Physiology · Cancer Research
Research interest
Research focused on Cancer research and Hepatocellular carcinoma, with related work in Breast cancer, Metastasis, MALAT1. Notable publications include 'Downregulation of long noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition via the PI3K-AKT pathway in breast cancer', 'MiR-338-3p Inhibits Hepatocarcinoma Cells and Sensitizes These Cells to Sorafenib by Targeting Hypoxia-Induced Factor 1α', and 'CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma'.
Multi-omics integration of TPX2 in prognostic prediction in resectable hepatocellular carcinoma
DCMF-PPI: a protein-protein interaction predictor based on dynamic condition and multi-feature fusion
TXSelect: A multi-task learning model to identify secretory effectors
Nab-paclitaxel plus S-1 followed by gemcitabine-oxaliplatin as first-line alternating sequential treatment of pancreatic ductal adenocarcinoma
Analysis on EZH2: mechanism identification of related CeRNA and its immunoassay in hepatocellular carcinoma
Pan-cancer analysis of SYNGR2 with a focus on clinical implications and immune landscape in liver hepatocellular carcinoma
Bioinformatic-based mechanism identification of E2F1-related ceRNA and E2F1 immunoassays in hepatocellular carcinoma
NEU4 inhibits motility of HCC cells by cleaving sialic acids on CD44
Dynamic Contrast-Enhanced Ultrasonography with Sonazoid for Diagnosis of Microvascular Invasion in Hepatocellular Carcinoma
CPEB3-mediated MTDH mRNA translational suppression restrains hepatocellular carcinoma progression
Novel Metabolomics Serum Biomarkers for Pancreatic Ductal Adenocarcinoma by the Comparison of Pre-, Postoperative and Normal Samples
Metabolic profiling analysis upon acylcarnitines in tissues of hepatocellular carcinoma revealed the inhibited carnitine shuttle system caused by the downregulated carnitine palmitoyltransferase 2
CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma
Raltitrexed Inhibits HepG2 Cell Proliferation via G<sub>0</sub>/G<sub>1</sub> Cell Cycle Arrest
Downregulation of long noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition via the PI3K-AKT pathway in breast cancer.
PubMed 2015cited by 151position: middle
Downregulation of the long noncoding RNA EGOT correlates with malignant status and poor prognosis in breast cancer
Specific N-glycans of Hepatocellular Carcinoma Cell Surface and the Abnormal Increase of Core-α-1, 6-fucosylated Triantennary Glycan via N-acetylglucosaminyltransferases-IVa Regulation
Comprehensive characterization and evaluation of hepatocellular carcinoma by LC–MS based serum metabolomics
MiR-338-3p Inhibits Hepatocarcinoma Cells and Sensitizes These Cells to Sorafenib by Targeting Hypoxia-Induced Factor 1α